HP moves into life sciences, while microfluidics market sees a surge in patent filings and suits 03 Jul 18
A new analysis of the thriving synthetic biology patent landscape has revealed the top patent owners and dealmakers in this space, as well as those appearing most often in the courtroom. Among its key findings are that Hewlett Packard (HP) has expanded into the life sciences arena and that the microfluidics market is booming. What’s more, a look at patenting activity by jurisdiction shows a stark contrast between the behaviours of US and Chinese players – and plenty of opportunities for collaboration between the two.
Want to read more?
Register to access two of our subscriber-only articles per month
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts
What our customers are saying
Straight talk on key IP issues, IAM aims to provide executive managers with the business perspective that often gets lost in technical jargon and legal details.
Senior vice president of intellectual property
The Nielsen Company
Subscribe to receive access to the full range of premium business intelligence, insights and analysis, as well as our IP directories, guides and daily news.
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email